Sigma | Evaluate

Sosei deal marks Allergan’s return to business as usual

September 01, 2015

The defensive anti-chain engulfs Ariad

August 06, 2015

For its next oncology trick Astra looks to neuroscience

October 20, 2014

Interview – Acquisitions to brighten Horizon

May 01, 2014

FDA to re-evaluate women’s health devices

December 20, 2013

Jazz plays the M&A song again

June 13, 2013

Can kicked down the road on diabetes drug cancer risks

May 24, 2013

Preladenant failure marks another Parkinson’s pipeline disappointment

December 24, 2012

Midcap players ask Europe to bring it on in 2013

May 03, 2012

Slow Q1 for VC funding points to another challenging year ahead

March 27, 2012

Vantage Point - In valley of death funding solutions are gradually emerging

Load More